Article

Clinical Trials Arena Excellence Awards: Science 37

Congratulations on the Site Innovation award—what core R&D site problem did you target first, and…

Blog

Specialized Care, Universal Access: A New Era for Pediatric Clinical Research

Author: BouaSy Huneycutt, MD, Medical Director, Pediatric Medicine For any parent, a child’s illness is a…

Article

Science 37 Becomes First FDA-Inspected Site to Deliver Clinical Trials to Patients’ Homes

Clinical trials are the research studies required to test the safety and effectiveness of new…

Article

Science 37 Honored for Site Innovation in the 2025 Clinical Trials Arena Excellence Awards

Science 37, the industry-leading patient access company, has won the Research and Development award in…

Podcast

Meet SCRS Global Impact Partner: Science 37

Meet SCRS Global Impact Partner, Science 37! Dr. Debra Weinstein, Vice President of Internal Medicine, discusses…

Podcast

Tyler Van Horn - Science 37 Note to File: A Clinical Research Podcast

We talk to Science 37 CEO Tyler Van Horn and discuss the past, present and…

Podcast

What is Decentralized Clinical Research?

In this episode of Nursing Beyond the Bedside, Brooke Silva shares her transformative journey from…

Report

Direct-to-Patient Site Fact Sheet

Science 37’s Direct-to-Patient Site empowers clinical trial sponsors to access 100% of their target patient…

Case Study

Exceeded Contracted Enrollment Goal in Phase 2 Rare Disease Study

As the top enrolling site among 52 research locations, Science 37 enrolled 21% of all…

Scientific Poster

Delivering Results: Science 37’s Direct-to-Patient Site for CNS Trials

extensive experience implementing these models in practice—building real-world evidence, refining methodologies, and advancing research in…

Case Study

Enrolling 100% of Total Participants for a Phase 3 Rare Cardiology Trial

Science 37 enrolled all study participants across 19 U.S. states as a single Direct-to-Patient Site,…

Case Study

Enrolling 72 Patients within 8 Months for a Phase 3 Cardiology Trial

Science 37 supported a Phase 3 atrial fibrillation trial, overcoming strict protocol criteria, an older…